MX2023002418A - Metodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas. - Google Patents

Metodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas.

Info

Publication number
MX2023002418A
MX2023002418A MX2023002418A MX2023002418A MX2023002418A MX 2023002418 A MX2023002418 A MX 2023002418A MX 2023002418 A MX2023002418 A MX 2023002418A MX 2023002418 A MX2023002418 A MX 2023002418A MX 2023002418 A MX2023002418 A MX 2023002418A
Authority
MX
Mexico
Prior art keywords
disease
atherosclerosis
baseline
increase
level
Prior art date
Application number
MX2023002418A
Other languages
English (en)
Spanish (es)
Inventor
Diana Kerwin
Jason Camm
Original Assignee
Beren Therapeutics P B C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beren Therapeutics P B C filed Critical Beren Therapeutics P B C
Publication of MX2023002418A publication Critical patent/MX2023002418A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2023002418A 2020-08-27 2021-08-27 Metodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas. MX2023002418A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (1)

Publication Number Publication Date
MX2023002418A true MX2023002418A (es) 2023-07-11

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023002418A MX2023002418A (es) 2020-08-27 2021-08-27 Metodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas.

Country Status (14)

Country Link
US (2) US20240000826A1 (cg-RX-API-DMAC10.html)
EP (1) EP4203974A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023543131A (cg-RX-API-DMAC10.html)
KR (1) KR20230104119A (cg-RX-API-DMAC10.html)
CN (1) CN116322644A (cg-RX-API-DMAC10.html)
AU (1) AU2021331487A1 (cg-RX-API-DMAC10.html)
CA (1) CA3189915A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023003656A2 (cg-RX-API-DMAC10.html)
CR (1) CR20230135A (cg-RX-API-DMAC10.html)
IL (1) IL300805A (cg-RX-API-DMAC10.html)
JO (1) JOP20230043A1 (cg-RX-API-DMAC10.html)
MX (1) MX2023002418A (cg-RX-API-DMAC10.html)
PE (1) PE20231169A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022047249A1 (cg-RX-API-DMAC10.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
WO2013155485A2 (en) * 2012-04-13 2013-10-17 Alessia Fornoni Method of using cyclodextrin

Also Published As

Publication number Publication date
EP4203974A1 (en) 2023-07-05
CA3189915A1 (en) 2022-03-03
IL300805A (en) 2023-04-01
CN116322644A (zh) 2023-06-23
KR20230104119A (ko) 2023-07-07
EP4203974A4 (en) 2024-08-07
JP2023543131A (ja) 2023-10-13
JOP20230043A1 (ar) 2023-02-27
CR20230135A (es) 2023-07-19
CO2023003656A2 (es) 2023-08-09
AU2021331487A1 (en) 2023-03-16
WO2022047249A1 (en) 2022-03-03
US20240000826A1 (en) 2024-01-04
US20230091966A1 (en) 2023-03-23
PE20231169A1 (es) 2023-07-26

Similar Documents

Publication Publication Date Title
Dhaun et al. Blood pressure–independent reduction in proteinuria and arterial stiffness after acute endothelin-A receptor antagonism in chronic kidney disease
Bell et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines
Dijkstra et al. Editor's choice–spinal cord ischaemia in endovascular thoracic and thoraco-abdominal aortic repair: review of preventive strategies
Fudim et al. Role of volume redistribution in the congestion of heart failure
Osherov et al. Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
Sun Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role associated with atherosclerosis
CR20230135A (es) Métodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas
MacRae Vascular access and cardiac disease: is there a relationship?
Hackl et al. COPART risk score predicts long-term mortality in peripheral arterial occlusive disease
Ledingham Heyde's syndrome: exploring the link between aortic stenosis and an acquired bleeding disorder
Abbott et al. Treatment of a Left Internal Mammary Artery to Pulmonary Artery Fistula with Polytetrafluoroethylene Covered Stents: A Case Report and Review of the Literature
Bron et al. Asymptomatic high flow subclavian steal in a patient with hemodialysis access
Rehman et al. Pulmonary hypertension and leading factors in patients undergoing dialysis.
Khot et al. From congenital variants to critical clues: A radiologic review of inferior vena cava pathologies
Magbri et al. Decreased incidence of clotted AV access in hemodialysis patients after the implementation of follow up program
Panfilov et al. Frozen Elephant Trunk Technique to Treat Extensive Thoracic Aortic Mural Thrombus
Schiffl The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients
Khan et al. Successful treatment of giant left subclavian artery pseudoaneurysm abutting the arch of the aorta and descending aorta
Hong et al. CT and MRI evaluation of the Fontan pathway: pearls and pitfalls
Komukai et al. Stent Failure due to Simultaneous Aggressive Neoatherosclerosis of First and Current Generation Drug Eluting Stents
Pande et al. Complete resolution of extensive thrombosis of atheromatous non-aneurysmal descending aorta and pulmonary embolism with warfarin therapy
Babic et al. Regarding “Significant long-term predictors of reintervention following percutaneous subclavian artery revascularization”
Sauvanet Complications chirurgicalesdes pancréatectomies
Fahrni et al. Percutaneous closure of adjunctive arteriovenous fistulas after surgical reconstruction of iliac veins
Katikaneni et al. Antiphospholipid syndrome (APS)-an update on clinical features and treatment options